Trump mandates U.S. generic drug production by 2028, imposing escalating tariffs on imports to boost domestic manufacturing.

The president said Tuesday he would maintain duty-free treatment for qualifying goods the next two years before hiking the tariffs in ensuing years.

While the possibility of levies on branded pharmaceuticals have had a limited impact on drugmaker revenues, tariffs of up to 200% on copycat medicines could — depending on the…

Trump has been pressuring drugmakers through his most-favored-nation drug pricing policy to lower prices to what people pay in other high-income countries.

US to impose steep tariffs on generic medicine imports from Aug 2028

Trump announces a tariff timeline for generic drugs, starting with zero tariffs for a year, then escalating to 200%.